Linde Healthcare Continues to Support Innovation in Advanced Respiratory Care

Linde Healthcare, a global business of The Linde Group, has announced the new beneficiaries of its REALfund initiative, a programme supporting ideas and projects with the potential to improve patient outcomes and health economics across the wide field of respiratory medicine.

Selected from many high quality applications from leading clinics and research organisations around the world, three grantees of the REALfund will receive funds to support their innovative research:

  • PD Johannes Bickenbach MD and Professor Michael Dreher MD, University Hospital Aachen, Germany, will investigate if exacerbations of invasively mechanically ventilated COPD patients can be predicted by an algorithm based on software analysis of data which will be read out from the ventilator.
  • Thomas Bitter MD, Heart and Diabetes Centre Bad Oeynhausen, Germany, will study if high flow oxygen therapy could serve as a new therapeutic approach to treat patients suffering from Cheyne-Stokes respiration associated with Chronic Heart Failure.
  • Professor Christopher H. Fanta MD, Brigham and Women’s hospital, Harvard Medical School, Boston, USA, plans to develop a smartphone app which is able to alert COPD patients about deterioration in their breathing and to provide recommendations for patient-initiated first actions to prevent serious exacerbations of their conditions.

Dr Christian Wojczewski, Head of Linde Healthcare states: "Linde Healthcare continues to be committed to co-operating with researchers from around the world to support research and innovative developments in the area of respiratory medicine. The newly awarded REALfund grants fit very well into Linde Healthcare's footprint as global healthcare organisation specialising along an integrated respiratory care path. The work of these researchers, when realised, will help healthcare professionals, support healthcare systems and further improve the quality of care and life for patients."

Grantees of the REALfund are selected with the help of medical and scientific experts and will be supported in their continued research. Dr Konstantin Fiedler, Head of Innovation at Linde Healthcare states: "The aim of Linde Healthcare’s REALfund initiative is to seek and reward ideas that have real potential to be developed into better respiratory care solutions for patients. We are proud of having received many high-quality applications from different regions around the world. We commend all applicants to the fund for their commitment to innovation and idea development in this area of healthcare. The grantees saw the potential in their projects and we at Linde Healthcare are delighted to recognise and reward the ideas that will truly benefit patients."

For further information about the REALfund, please visit:
http://www.linde-realfund.com

About Linde Healthcare
Linde Healthcare is a global leader specialising along an integrated respiratory care path. It combines pharmaceutical gases, medical devices, services and clinical care into solutions with the patient in mind. Its products and services make a difference in the lives of its patients and to its healthcare partners in the care continuum from hospital to home. A global business unit of The Linde Group, it is present in over 60 countries and generated revenues of EUR 3.059 bn in 2014 and employs 16,643 employees.

About The Linde Group
In the 2014 financial year, The Linde Group generated revenue of EUR 17.047 bn, making it the largest gases and engineering company in the world with approximately 65,500 employees working in more than 100 countries worldwide. The strategy of The Linde Group is geared towards long-term, profitable growth and focuses on the expansion of its international business with forward-looking products and services. Linde acts responsibly towards its shareholders, business partners, employees, society and the environment - in every one of its business areas, regions and locations across the globe. The company is committed to technologies and products that unite the goals of customer value and sustainable development.

Most Popular Now

Gait Assessed with Body-Worn Sensors may…

Body-worn sensors used at home and in clinic by people with mild Alzheimer's to assess walking could offer a cost-effective way to detect early disease and monitor progression of the...

Applications for the G4A Global Accelera…

Founded in 2013 in Berlin initially giving out grants to innovative healthcare apps, G4A Accelerator is now a global program dedicated to helping innovative health & care startups grow and...

Siemens Healthineers Fully on Track to M…

Siemens Healthineers AG has posted good business figures in the first quarter following its successful initial public offering on March 16, 2018. Year-over-year revenue was up four percent at EUR...

How to Build GDPR and HIPAA Compliant He…

The adoption of cloud and mobile technologies in healthcare is disrupting the services delivery models, and responsibilities and risks for involved actors. By their very nature, eHealth applications collect and...

Computers Equal Radiologists in Assessin…

Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led...

The Big Ethical Questions for Artificial…

AI in healthcare is developing rapidly, with many applications currently in use or in development in the UK and worldwide. The Nuffield Council on Bioethics examines the current and potential...

Consultation: Transformation Health and …

The present report provides an analysis of the results of consultation activities carried out by the European Commission in preparation of a Communication on the Transformation of Health and Care...

Novartis Launches FocalView App, Providi…

Novartis announced the launch of its FocalView app, an ophthalmic digital research platform created with ResearchKit. FocalView aims to allow researchers to track disease progression by collecting real-time, self-reported data...

International Masters's in Medical Infor…

The Master of Science Program in Medical Informatics (MMI) at European Campus Rottal-Inn (ECRI)in Pfarrkirchen - a branch of the Deggendorf University of Applied Sciences (THD - Technische Hochschule Deggendorf)...

Data in the EU: Commission Steps Up Effo…

The European Commission is putting forward a set of measures to increase the availability of data in the EU, building on previous initiatives to boost the free flow of non-personal...

Philips Expands its Sleep & Respirat…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that it has acquired NightBalance, a digital health scale-up company based in the Netherlands, that has...

A New Way to Watch Brain Activity in Act…

It's a neuroscientist's dream: being able to track the millions of interactions among brain cells in animals that move about freely, behaving as they would under natural circumstances. New technology...